Karolinska Development: Additional cash from divestment
Research Note
2019-06-27
22:55
Earlier today, Karolinska Development announced that they had sold its entire ownership in Pharmanest. The divestment brings approximately SEK 23 million to Karolinska Development. It is welcoming news, as the investment entity is in need for cash.
AH
Anders Hedlund
Disclosures and disclaimers